![](/img/cover-not-exists.png)
Mechanism-based approach using a biomarker response to evaluate tocilizumab subcutaneous injection in patients with rheumatoid arthritis with an inadequate response to synthetic DMARDs (MATSURI study)
Ohta, Shuji, Tsuru, Tomomi, Terao, Kimio, Mogi, Seiji, Suzaki, Midori, Shono, Eisuke, Ishida, Yoshimasa, Tarumi, Eriko, Imai, MasatoVolume:
54
Language:
english
Journal:
The Journal of Clinical Pharmacology
DOI:
10.1002/jcph.185
Date:
January, 2014
File:
PDF, 1.40 MB
english, 2014